Key result
Adding plasma LCN2 to echocardiography did not significantly improve AUC for distinguishing pulmonary artery ligation from sham in rats (0.945 vs 0.914; ΔAUC +0.031; 95% CI 0.000–0.089; p=0.174).
Why the study?
Isolated right pulmonary artery ligation redirects flow to the contralateral lung, and it was unclear whether adding plasma lipocalin-2 (LCN2) to echocardiography improves discrimination between ligation and sham operation.
Does adding plasma lipocalin-2 to echocardiography improve discrimination between right pulmonary artery ligation and sham operation in male Sprague-Dawley rats?
Does adding plasma lipocalin-2 to echocardiography improve discrimination between right pulmonary artery ligation and sham operation in male Sprague-Dawley rats?
Answers are grounded in this paper and cite their sources.
In a rat model of isolated right pulmonary artery ligation, adding plasma lipocalin-2 to echocardiography did not significantly improve the overall AUC for discriminating ligation from sham operation, though it modestly improved integrated discrimination and continuous prediction of right ventricular systolic pressure.
Isolated right pulmonary artery ligation redirects flow to the contralateral lung. We tested whether adding plasma lipocalin-2 (LCN2) to echocardiography improves discrimination between ligation and sham operation. Male Sprague–Dawley rats undergoing ligation or sham operation (n = 16 each) were assessed at postoperative weeks 4, 8, or 12 by echocardiography, right-heart catheterization, histology, and LCN2 immunoassay. Leave-one-out ridge-logistic regression compared echocardiographic models with and without LCN2. The models distinguish ligation from sham and do not grade pulmonary hypertension. At week 4, LCN2, right ventricular systolic pressure, medial wall thickness percentage, and collagen volume fraction differed between groups; echocardiographic indices did not differ significantly. This is between-group separation in different animals, not earlier detection within one animal. The area under the curve (AUC) was 0.914 (95% confidence interval [CI] 0.798–0.992) without LCN2 and 0.945 (0.847–1.000) with LCN2, a nonsignificant increase (ΔAUC +0.031; 95% CI 0.000–0.089; p = 0.174). The supported increments were in integrated discrimination (0.061; 95% CI 0.031–0.095) and continuous prediction of right ventricular systolic pressure (leave-one-out R2 0.819 to 0.847). The in-sample nested change in R2 was 0.028 (95% CI 0.0008–0.087; false-discovery-rate q = 0.004). These internal results establish neither residual severity grading nor replacement of right-heart catheterization.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied Isolated right pulmonary artery ligation (rat model) (n=32). Adding plasma lipocalin-2 (LCN2) to echocardiography vs. Echocardiography without plasma LCN2 was evaluated on Discrimination between right pulmonary artery ligation and sham operation (area under the curve, AUC) (ΔAUC +0.031, 95% CI 0.000-0.089, p=0.174). Adding plasma LCN2 to echocardiography did not significantly improve AUC for distinguishing pulmonary artery ligation from sham in rats (0.945 vs 0.914; ΔAUC +0.031; 95% CI 0.000–0.089; p=0.174).
Synapse has enriched 10 related papers. Consider them for comparative context: